We have also previously reported increased protein expression of NLRP3 in post-mortem brain tissue of BD patients and that PBMCs of patients with mood disorders can be increasingly sensitive to NLRP3 activation, possibly due to underlying inflammation [14, 16]. The gene discussed is NLRP3; the disease is mood disorder.